These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 32964651)
1. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool. Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651 [TBL] [Abstract][Full Text] [Related]
2. Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV. Trunfio M; De Francesco D; Vai D; Medina C; Milesi M; Domini S; Alcantarini C; Imperiale D; Bonora S; Di Perri G; Calcagno A AIDS Behav; 2022 Jul; 26(7):2203-2211. PubMed ID: 34982319 [TBL] [Abstract][Full Text] [Related]
3. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure. Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738 [TBL] [Abstract][Full Text] [Related]
4. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders? Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542 [TBL] [Abstract][Full Text] [Related]
5. HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project. Ku NS; Lee Y; Ahn JY; Song JE; Kim MH; Kim SB; Jeong SJ; Hong KW; Kim E; Han SH; Song JY; Cheong HJ; Song YG; Kim WJ; Kim JM; Smith DM; Choi JY HIV Med; 2014 Sep; 15(8):470-7. PubMed ID: 24580888 [TBL] [Abstract][Full Text] [Related]
6. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil. Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557 [TBL] [Abstract][Full Text] [Related]
7. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic. Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497 [TBL] [Abstract][Full Text] [Related]
8. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study. Nyundo AA PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133 [TBL] [Abstract][Full Text] [Related]
9. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study. Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530 [TBL] [Abstract][Full Text] [Related]
10. Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity. Robbins RN; Scott TM; Gouse H; Marcotte TD; Rourke SB Curr Top Behav Neurosci; 2021; 50():429-478. PubMed ID: 32677005 [TBL] [Abstract][Full Text] [Related]
13. A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review. Bloch M; Kamminga J; Jayewardene A; Bailey M; Carberry A; Vincent T; Quan D; Maruff P; Brew B; Cysique LA Clin Infect Dis; 2016 Sep; 63(5):687-693. PubMed ID: 27325690 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania. Flatt A; Gentry T; Kellett-Wright J; Eaton P; Joseph M; Urasa S; Howlett W; Dekker M; Kisoli A; Rogathe J; Henderson L; Lewis T; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska EB; Akinyemi R; Gray WK; Walker RW; Dotchin CL; Quaker AS; Makupa PC; Paddick SM Int Psychogeriatr; 2023 Jul; 35(7):339-350. PubMed ID: 33757616 [TBL] [Abstract][Full Text] [Related]
15. Validity of the International HIV Dementia Scale in South Africa. Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ AIDS Patient Care STDS; 2011 Feb; 25(2):95-101. PubMed ID: 21214343 [TBL] [Abstract][Full Text] [Related]
16. Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke's Cognitive Examination-Revised, and Montreal Cognitive Assessment. Ridley N; Batchelor J; Draper B; Demirkol A; Lintzeris N; Withall A J Clin Exp Neuropsychol; 2018 Mar; 40(2):107-122. PubMed ID: 28436744 [TBL] [Abstract][Full Text] [Related]
17. High prevalence of neurocognitive disorders observed among adult people living with HIV/AIDS in Southern Ethiopia: A cross-sectional study. Debalkie Animut M; Sorrie MB; Birhanu YW; Teshale MY PLoS One; 2019; 14(3):e0204636. PubMed ID: 30883557 [TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of the accuracy of the Addenbrooke's Cognitive Examination (ACE) and the Addenbrooke's Cognitive Examination-Revised (ACE-R) in the detection of dementia. Larner AJ; Mitchell AJ Int Psychogeriatr; 2014 Apr; 26(4):555-63. PubMed ID: 24423470 [TBL] [Abstract][Full Text] [Related]
19. The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders. Costaggiu D; Pinna E; Serchisu L; Barcellona D; Piano P; Ortu F; Marongiu F; Mandas A AIDS Care; 2021 Mar; 33(3):357-363. PubMed ID: 32183560 [TBL] [Abstract][Full Text] [Related]
20. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa. Joska JA; Witten J; Thomas KG; Robertson C; Casson-Crook M; Roosa H; Creighton J; Lyons J; McArthur J; Sacktor NC AIDS Behav; 2016 Aug; 20(8):1621-31. PubMed ID: 26860536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]